-transparent.png){kind=logo}
Chronic lymphocytic leukaemia is the commonest of the leukaemias and occurs most often in the elderly. The identification of presenting features that correlate adversely or favourably with survival has allowed the rational development of new treatment strategies.
Related Publications
T D Karmiris, and
T A Lister, and
A Z Rohatiner
October 2021,
Ugeskrift for laeger,
T D Karmiris, and
T A Lister, and
A Z Rohatiner
April 1999,
British journal of haematology,
T D Karmiris, and
T A Lister, and
A Z Rohatiner
August 2016,
Critical reviews in oncology/hematology,
T D Karmiris, and
T A Lister, and
A Z Rohatiner
March 2008,
Lancet (London, England),
T D Karmiris, and
T A Lister, and
A Z Rohatiner
June 1987,
Bailliere's clinical haematology,
T D Karmiris, and
T A Lister, and
A Z Rohatiner
February 2017,
Nature reviews. Disease primers,
T D Karmiris, and
T A Lister, and
A Z Rohatiner
January 2017,
Nature reviews. Disease primers,
T D Karmiris, and
T A Lister, and
A Z Rohatiner
February 2009,
Anticancer research,
T D Karmiris, and
T A Lister, and
A Z Rohatiner
January 2001,
Clinical medicine (London, England),
T D Karmiris, and
T A Lister, and
A Z Rohatiner
July 1974,
The Medical journal of Australia,
